Imatinib Completed Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00483366Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors (Closed to Accrual 12/11/2008)
NCT00253565Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors
NCT00084513Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer